Literature DB >> 26278659

Intranasal immunization with protective antigen of Bacillus anthracis induces a long-term immunological memory response.

Sun-Je Woo1, Seok-Seong Kang1, Sung-Moo Park2, Jae Seung Yang3, Man Ki Song3, Cheol-Heui Yun2, Seung Hyun Han4.   

Abstract

Although intranasal vaccination has been shown to be effective for the protection against inhalational anthrax, establishment of long-term immunity has yet to be achieved. Here, we investigated whether intranasal immunization with recombinant protective antigen (rPA) of Bacillus anthracis induces immunological memory responses in the mucosal and systemic compartments. Intranasal immunization with rPA plus cholera toxin (CT) sustained PA-specific antibody responses for 6 months in lung, nasal washes, and vaginal washes as well as serum. A significant induction of PA-specific memory B cells was observed in spleen, cervical lymph nodes (CLNs) and lung after booster immunization. Furthermore, intranasal immunization with rPA plus CT remarkably generated effector memory CD4(+) T cells in the lung. PA-specific CD4(+) T cells preferentially increased the expression of Th1- and Th17-type cytokines in lung, but not in spleen or CLNs. Collectively, the intranasal immunization with rPA plus CT promoted immunologic memory responses in the mucosal and systemic compartments, providing long-term immunity.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Intranasal immunization; Memory response; Protective antigen

Mesh:

Substances:

Year:  2015        PMID: 26278659     DOI: 10.1016/j.molimm.2015.08.002

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  1 in total

1.  Identification of the pXO1 plasmid in attenuated Bacillus anthracis vaccine strains.

Authors:  Xudong Liang; Huijuan Zhang; Enmin Zhang; Jianchun Wei; Wei Li; Bingxiang Wang; Shulin Dong; Jin Zhu
Journal:  Virulence       Date:  2016-03-30       Impact factor: 5.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.